Mark Chin's Net Worth

$251 Thousand

Estimate Recalculated Nov 7, 2024 11:54AM EST

Who is Mark Chin?

Mark Chin does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Pyxis Oncology, Inc., Harpoon Therapeutics, Inc., Iterum Therapeutics plc, IMARA Inc., and Disc Medicine, Inc..

SEC CIK

Mark Chin's CIK is 0001734389

Past Insider Trading and Trends

2021 was Mark Chin's most active year for acquiring shares with 7 total transactions. Mark Chin's most active month to acquire stocks was the month of May. 2024 was Mark Chin's most active year for disposing of shares, totalling 5 transactions. Mark Chin's most active month to dispose stocks was the month of February. 2022 saw Mark Chin paying a total of $47,376.75 for 399,233 shares, this is the most they've acquired in one year. In 2022 Mark Chin cashed out on 36,798 shares for a total of $0.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Pyxis Oncology, Inc. (PYXS) Snapshot price: $3.45

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-1.75M
$3.05
-$5,324,571.05
0
Apr 21
Form 4
∞
66.83K
—
—
66.83K
Mar 31
Form 4
∞
1.75M
$16.00
—
1.75M
Oct 13
Form 4
—
0
—
—
0
Oct 7
Form 3
—
0
—
—
0
No matching records found

Harpoon Therapeutics, Inc. (HARP) No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-12.80K
—
—
0
Mar 8 - Mar 11
Form 4
+9.14%
1.07K
—
—
12.8K
Jan 1
Form 4
+74.31%
5K
—
—
11.73K
Nov 27
Form 4
+82.16%
3.04K
—
—
6.73K
Oct 1
Form 4
+102.03%
18.66K
—
—
36.94K
Jul 1
Form 4
—
0
—
—
0
Jun 22
Form 4
∞
18.29K
—
—
18.29K
Apr 1
Form 4
—
0
—
—
0
Jun 22
Form 4/A
—
0
—
—
0
May 4
Form 4
—
0
—
—
0
May 4
Form 4
—
0
—
—
0
May 28
Form 4
-1.40%
-36.56K
$17.01
-$621,990.16
2.57M
Dec 13 - Dec 17
Form 4
-9.79%
-283.20K
$17.75
-$5,025,685.88
2.61M
Dec 6 - Dec 10
Form 4
—
0
—
—
0
Jun 3
Form 4/A
—
0
—
—
0
Feb 7
Form 4
∞
2.89M
$14.00
—
2.89M
Nov 9 - Feb 12
Form 3
—
0
—
—
0
No matching records found

Iterum Therapeutics plc (ITRM) Snapshot price: $1.12

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+646.27%
15.85K
—
—
18.31K
Jun 15
Form 4
∞
36.8K
—
—
36.8K
Jun 23
Form 4
—
0
—
—
0
Jun 15
Form 4
—
0
—
—
0
Jun 23
Form 4
-100.00%
-11.86K
—
—
0
Jul 28
Form 4
+92.67%
5.7K
—
—
11.86K
Jul 1
Form 4
-100.00%
-1.09M
—
—
0
Apr 7
Form 4
—
0
—
—
0
Jan 21
Form 4
—
0
—
—
0
Jun 13
Form 4
∞
6.15K
—
—
6.15K
May 24
Form 4
+5.62%
58K
$6.10
$353,800.00
1.09M
Oct 30
Form 4
∞
1.03M
$13.00
—
1.03M
May 30
Form 4
—
0
—
—
0
May 24
Form 3
—
0
—
—
0
No matching records found

IMARA Inc. (ELVN) Snapshot price: $21.44

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 2
Form 4
+131.92%
1.33M
$6.00
$7,999,998.00
2.34M
Jul 16
Form 4
—
0
—
—
0
Jun 29
Form 4
∞
1.55M
$16.00
—
1.55M
Mar 16
Form 3
—
0
—
—
0
No matching records found

Disc Medicine, Inc. (IRON) Snapshot price: $50.35

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 12
Form 4
—
0
—
—
0
Jun 9
Form 4
—
0
—
—
0
Dec 29
Form 3
—
0
—
—
0
No matching records found